Works matching IS 13899600 AND DT 2022 AND VI 21 AND IP 2
Results: 14
Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 157, doi. 10.1007/s10689-021-00261-1
- By:
- Publication type:
- Article
Questioning the validity of clinically available breast cancer polygenic risk scores: comparison of two labs reveals discrepancies.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 125, doi. 10.1007/s10689-021-00260-2
- By:
- Publication type:
- Article
The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 241, doi. 10.1007/s10689-021-00259-9
- By:
- Publication type:
- Article
CDH1 pathogenic variants and cancer risk in an unselected patient population.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 235, doi. 10.1007/s10689-021-00257-x
- By:
- Publication type:
- Article
Recurring pathogenic variants in the BRCA2 gene in the Ethiopian Jewish population. Founder mutations?
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 121, doi. 10.1007/s10689-021-00255-z
- By:
- Publication type:
- Article
Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 229, doi. 10.1007/s10689-021-00252-2
- By:
- Publication type:
- Article
Extended gene panel testing in lobular breast cancer.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 129, doi. 10.1007/s10689-021-00241-5
- By:
- Publication type:
- Article
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 197, doi. 10.1007/s10689-021-00256-y
- By:
- Publication type:
- Article
"I wish that there was more info": characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 143, doi. 10.1007/s10689-021-00251-3
- By:
- Publication type:
- Article
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM<sub>5</sub>™) for lynch syndrome risk assessment in a diverse population.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 167, doi. 10.1007/s10689-021-00243-3
- By:
- Publication type:
- Article
A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 137, doi. 10.1007/s10689-021-00242-4
- By:
- Publication type:
- Article
Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 189, doi. 10.1007/s10689-021-00250-4
- By:
- Publication type:
- Article
A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer.
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 181, doi. 10.1007/s10689-021-00249-x
- By:
- Publication type:
- Article
First international workshop of the ATM and cancer risk group (4-5 December 2019).
- Published in:
- Familial Cancer, 2022, v. 21, n. 2, p. 211, doi. 10.1007/s10689-021-00248-y
- By:
- Publication type:
- Article